'The company's transition from an individuals-driven private firm to a board-driven listed public one will be carried out in a well-thought-through and well-executed manner.' IMAGE: BharatPe......
Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports. IMAGE: Donald Trump......
Soon, those not connected with the Hindi film segment in any way will also be able to reap the benefits of the sector’s double-digit growth, with Third Eye Cinema Fund (TCEF), a......
In yet another legal battle between a multinational company and domestic drug manufacturing firms, Merck Sharp and Dohme has moved the Delhi High Court against Mumbai-based Glenmark......
The face of the Indian drug manufacturing industry has changed over the past year or so, with a string of changes in the top management of major pharmaceutical companies. Many attribute this to the......